Alcon

ALC53

$85.99arrow_drop_up0.49%$0.42

ALC53

$85.99

arrow_drop_up0.49%$0.42

Performance History

Key Stats
Open	$85.96
Prev. Close	$85.57
EPS	2.34

Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	85.65	87.68
52 Week Range	69.44	101.10

Ratios







EPS	2.34

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alcon (ALC)

Alcon Inc (ALC) is a leading global medical company specializing in eye care products and technologies. With a rich history that spans over 70 years, Alcon has established itself as a trusted name in the ophthalmic industry. The company's mission is to enhance sight and improve people's lives by offering innovative solutions for vision care.

One of the key highlights of Alcon is its extensive portfolio of products, which includes surgical equipment, contact lenses, and pharmaceuticals. The company's surgical products range from advanced laser systems to intraocular lenses, enabling surgeons to perform complex procedures with precision and efficiency. In addition, Alcon's contact lens division offers a wide range of options for vision correction, catering to the diverse needs of patients.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. David J. Endicott
Headquarters: Geneva
Employees: 25000
Exchange: NYSE

Keep an eye on Alcon

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alcon 's (ALC) price per share?

The current price per share for Alcon (ALC) is $85.99. The stock has seen a price change of $0.42 recently, indicating a 0.49% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alcon (ALC)?

For Alcon (ALC), the 52-week high is $101.1, which is 17.57% from the current price. The 52-week low is $69.44, the current price is 23.83% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alcon (ALC) a growth stock?

Alcon (ALC) has shown an average price growth of -4.13% over the past three years. It has received a score of 53 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alcon as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alcon (ALC) stock price performance year to date (YTD)?

As of the latest data, Alcon (ALC) has a year-to-date price change of 11.62%. Over the past month, the stock has experienced a price change of -9.01%. Over the last three months, the change has been -10.51%. Over the past six months, the figure is -4.2%. Looking at a longer horizon, the five-year price change stands at 51.95%.

help

Is Alcon (ALC) a profitable company?

Alcon (ALC) has a net income of $1.04B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.57% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.53% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $10.09B, with a revenue growth rate of 15.77%, providing insight into the company's sales performance and growth. The gross profit is $5.61B. Operating income is noted at $1.04B. Furthermore, the EBITDA is $1.87B.

help

What is the market capitalization of Alcon (ALC)?

Alcon (ALC) has a market capitalization of $42.53B. The average daily trading volume is 85.97, indicating the stock's liquidity and investor engagement.

News

OPHTHALMOLOGY DEVICES

MARKET ANALYSIS

INDUSTRY TRENDS

COMPETITIVE STRATEGIES

Nov 21, 2024

Ophthalmology Devices Market Analysis Report 2025-2030: Industry Trends, Market Shares and Competitive Strategies

RETINAL SURGERY DEVICES

EUROPE

MARKET GROWTH

TECHNOLOGICAL ADVANCEMENTS

RETINAL DISEASES

Oct 23, 2024

2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements

TECHNOLOGICAL ADVANCEMENTS

Oct 1, 2024

Ophthalmic Devices Market Is Expected To Reach Revenue Of USD 120.3 Bn By 2033, At 5.1% CAGR: Dimension Market Research.